Corona Remedies makes bumper debut on the BSE [Healthcare]
AI Summary1 min read
TL;DR
Corona Remedies debuted strongly on the BSE, focusing on pharmaceutical manufacturing and marketing with a diverse portfolio across therapeutic areas like women's healthcare and pain management.
Tags
Pharmaceuticals & DrugsHealthcareCorona RemediesBSE debutpharmaceuticalshealthcarestock market
The company is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products. The company also has an associate which is involved in similar line of business. Its diversified product portfolio comprises brands that cater to a range of therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology and others/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory.